GlaxoSmithKline (GSK) has announced the FDA approval of four-strain seasonal influenza (flu) virus vaccine, Fluarix Quadrivalent, to immunize adults and children of three years age and more, in the US. The intramuscular vaccine is ...
GlaxoSmithKline (GSK) has announced FDA approval of raxibacumab anti-toxin as a combination therapy along with antibacterial drugs for the treatment of inhalational anthrax in both adult and pediatric patients with limited treatment ...
GlaxoSmithKline has launched a new program to reduce the environmental impact of GSK respiratory inhalers sent to landfills. The program, Complete the Cycle Recycle, is designed to help people to deposit their empty inhalers at ...
Tags: GlaxoSmithKline, GSK, program, GSK respiratory
For those with a taste for the best in life, the Ritz, Hilton and Malmaison are probably among the hotel brands of choice. But now a new entrant is hoping to shake things up – the NHS. And officials say it will shatter preconceptions ...
Tags: high-quality accommodation, NHS, English NHS
Actavis Group, a generic pharmaceuticals company, has gained FDA approval for Ropinirole extended-release tablets, 2mg, 4mg, 6mg, 8mg and 12mg. The company has started distribution of the generic version of GlaxoSmithKline's Requip XL. ...
GlaxoSmithKline (GSK), Ligand Pharmaceuticals' partner, has gained FDA priority review status for the supplemental new drug application for Promacta to treat thrombocytopenia in adult patients with chronic hepatitis C virus infection. ...
Tags: GlaxoSmithKline, GSK, promacta, thrombocytopenia
GlaxoSmithKline (GSK) and XenoPort have gained FDA approval for Horizant (gabapentin enacarbil) extended-release tablets for postherpetic neuralgia (PHN). A single 12-week principal efficacy trial and two supportive studies that met their ...
Outotec has appointed Ms Kirsi Nuotto MA as new Senior Vice President Human Capital and member of the Executive Board as of January 9th 2013. Ms Kirsi Nuotto 53, is joining Outotec from Cargotec Corporation where she has held the position ...
GlaxoSmithKline (GSK) has received FDA approval for Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. The approval is based on the results of the randomized, ...
Tags: advanced soft tissue sarcoma, STS, soft tissue sarcomas, GlaxoSmithKline
Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) has completed acquisition of Human Genome Sciences (HGS) for $3.6bn on an equity basis, or approximately $3 billion net of cash and debt. With the acquisition, all ...
Tags: GSK, GlaxoSmithKline, Human Genome Sciences
Human Genome Sciences (HGS) has rejected $2.6bn (£1.6bn) takeover bid offered by GlaxoSmithKline (GSK). GSK offered $13 per share, which is 81% premium to HGS closing price on 18 April 2012, of $7.17 per share. HGS has partnered ...
Tags: HGS, GSK, GlaxoSmithKline
GlaxoSmithKline (GSK) has announced an agreement with Aspen Global to divest majority of Classic Brands, including 25 non-promoted and genericised products in Australia for approximately £172m in cash. The divested brands include ...
Tags: Valtrex, Lamictal, Timentin, Amoxil, branded and generic pharmaceuticals
Mylan, a pharmaceutical company, has introduced lamivudine film coated tablets, 150mg and 300mg, in the UK and Italy. The generic version of GlaxoSmithKline's Epivir tablets is indicated as part of antiretroviral (ARV) combination therapy ...
Tags: Generic Epivir Tablets, lamivudine film coated tablets, HIV-infected
Liquidia Technologies has initiated multi-year product development collaboration with GlaxoSmithKline (GSK). Under the collaboration, GSK acquired exclusive rights to research and develop certain vaccine and inhaled product candidates ...
KineMed has entered into a multi-year R&D collaboration GlaxoSmithKline (GSK) to develop kinetic biomarkers. The collaboration will apply KineMed's biomarker discovery platform in therapeutic areas of interest to GSK. KineMed president ...
Tags: kinetic biomarkers, GlaxoSmithKline, KineMed's technology